Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Pharma-Bio Serv's share price for the quarter that ended in Jan. 2024 was $0.959. Pharma-Bio Serv's Shares Outstanding (EOP) for the quarter that ended in Jan. 2024 was 22.96 Mil. Therefore, Pharma-Bio Serv's market cap for the quarter that ended in Jan. 2024 was $22.02 Mil.
Pharma-Bio Serv's quarterly market cap
declined
from Jul. 2023 ($24.66 Mil) to Oct. 2023 ($19.51 Mil) but then
increased
from Oct. 2023 ($19.51 Mil) to Jan. 2024 ($22.02 Mil).
Pharma-Bio Serv's annual market cap
declined
from Oct. 2021 ($23.69 Mil) to Oct. 2022 ($19.73 Mil) and
declined
from Oct. 2022 ($19.73 Mil) to Oct. 2023 ($19.51 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Pharma-Bio Serv's Enterprise Value for Today is $0.49 Mil.
Pharma-Bio Serv Market Cap Historical Data
The historical data trend for Pharma-Bio Serv's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Pharma-Bio Serv's Market Cap
For the Health Information Services subindustry, Pharma-Bio Serv's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Pharma-Bio Serv's Market Cap Distribution in the Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Pharma-Bio Serv's Market Cap distribution charts can be found below:
* The bar in red indicates where Pharma-Bio Serv's Market Cap falls into.
Pharma-Bio Serv Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Pharma-Bio Serv's Market Cap for the fiscal year that ended in Oct. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Pharma-Bio Serv (OTCPK:PBSV) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Pharma-Bio Serv Market Cap Related Terms
Thank you for viewing the detailed overview of Pharma-Bio Serv's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Pharma-Bio Serv (Pharma-Bio Serv) Business Description
Pharma-Bio Serv Inc is a compliance and technology transfer services consulting firm. It also provides microbiological testing services and chemical testing services through its laboratory testing facility in Puerto Rico. It has three reportable segments: Puerto Rico technical compliance consulting which is the key revenue driver; United States technical compliance consulting; and Europe technical compliance consulting. The company offers solutions to the pharmaceutical, chemical, biotechnology, medical devices, cosmetic and food industries, and allied products companies.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
PBSV has been successfully added to your 